The ability to offer supplements at competitive price points for patients to take control of their health based on their results
Optimizing BV8-targeting agents, especially in combination with other checkpoint inhibitors or cellular therapies, could provide a multifaceted approach to disrupt tumor-promoting mechanisms and improve clinical outcomes in cancer patients
Delivery with melted ice packs You come home to find your compounded semaglutide delivery sitting on the porch
Significant discoloration suggests degradation or contamination
In the withdrawal trial, participants switched to placebo regained about 14% over the following year. Tapering, at least 1.2 g/kg of protein, resistance training, and follow-up reduce the risk, but no post-stop protocol guarantees maintenance
This article is exclusive to STAT+ subscribers Unlock this article plus daily intelligence on Capitol Hill and the life sciences industry by subscribing to STAT+